What's new in multifocal motor neuropathy in 2007-2008? Review

Research output: Contribution to journalArticlepeer-review


Several articles on multifocal motor neuropathy (MMN) have appeared in 2007 and 2008, broadening the boundaries of this neuropathy and improving its diagnosis. A number of retrospective studies confirmed the prolonged efficacy of high-dose intravenous immunoglobulins (IVIg) in this neuropathy. The efficacy of other immune therapies was not however, confirmed in other studies in MMN including a randomized controlled trial on mycophenolate mofetil as adjunctive therapy to IVIg. These negative results and the lack of new other studies on the cause of MMN should lead to some reconsideration on its pathogenesis.

Original languageEnglish
Pages (from-to)261-263
Number of pages3
JournalJournal of the Peripheral Nervous System
Issue number4
Publication statusPublished - Dec 2008


  • Conduction block
  • GM1
  • IVIg
  • Multifocal motor neuropathy
  • Mycophenolate mofetil

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)


Dive into the research topics of 'What's new in multifocal motor neuropathy in 2007-2008? Review'. Together they form a unique fingerprint.

Cite this